Sylvain Peuget

7PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 16, 2025
Reply to 'Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies'.

Sylvain Peuget, Galina Selivanova

|May 04, 2023
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation.

Sylvain Peuget, Galina Selivanova

|Jul 25, 2022
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.

Yue Zhan, Xiaolei Zhou, Sylvain Peuget

|Feb 24, 2022
Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization.

Marie-Stéphanie Aschtgen, Konstantinos Fragkoulis, Gema Sanz

|Jan 25, 2020
Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes.

Jiawei Zhu, Madhurendra Singh, Galina Selivanova

Pageof 2